Medtronic (MDT) News Today

Shares of Medtronic PLC (NYSE:MDT) are trading higher, supported by a strong quarterly report, raised guidance and a slew of bullish analyst actions.

• Positive Sentiment: Medtronic beat Q4 earnings estimates, sending shares up 4.1% after the company reported $1.26 EPS versus the $1.23 consensus. Medtronic Trading Up 4.1% After Earnings Beat
• Positive Sentiment: Management raised FY 2026 EPS guidance to $5.60–5.66 (versus a $5.55 consensus) and lifted revenue outlook above forecasts. Medtronic Updates FY 2026 Earnings Guidance
• Positive Sentiment: Leerink Partners upped its long-term EPS forecasts through FY 2030 and maintained a Strong-Buy rating, signaling confidence in Medtronic’s growth trajectory. Leerink Partners EPS Revisions
• Positive Sentiment: Sanford C. Bernstein raised its price target to $98 and kept an Outperform rating, while Citigroup lifted its target to $101 (Buy) and Truist to $96 (Hold). SCB Price Target Increase Citigroup Positive Forecast Truist Price Target Raise
• Positive Sentiment: Medtronic lifted its annual outlook and appointed new board directors as part of a strategic refresh following activist engagement. Medtronic Lifts Annual Outlook, Appoints New Directors
• Neutral Sentiment: Robert W. Baird increased its price target to $96 but retained a Neutral rating, suggesting limited near-term upside. Robert W. Baird Forecast
• Neutral Sentiment: William Blair made modest EPS estimate tweaks for 2026–2027 and kept a Hold rating, reflecting a wait-and-see stance. William Blair Research Note
• Negative Sentiment: Shares earlier gapped down, prompting some “time to sell” commentary amid profit-taking. Gap-Down Sell Signal
• Negative Sentiment: A recent Fool.com piece highlighted near-term struggles in device sales, underscoring lingering concerns about revenue consistency. High-Yield Healthcare Stock Article